Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Cole Foundation Injects $2.5 Million To Bolster Leukemia Research
Canada has received new support to recruit some of its best minds in pediatric leukemia research, thanks to the Cole Foundation. The family foundation has generously pledged $2.5 million to support up-and-coming, Montreal-based researchers at the Universitçİ de Montrçİal, McGill University and the Universitçİ du Quçİbec"s Institut national de la recherche scientifique - Institut Armand-Frappier. The Cole Foundation investment will include:
generic viagra online
Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect In Phase IIa Trial In Nocturia
Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, announces positive results from a Phase IIa clinical trial of its lead development compound VA106483 for nocturia. The trial showed that oral VA106483 was successful in producing a predictable and sustained anti-diuretic effect in patients, as determined by increased osmolality and decreased urine output. The study also found that VA106483 was generally well tolerated among the patient population.
News of the day
Study May Aid Efforts To Prevent Uncontrolled Cell Division In Cancer
Researchers from the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine have uncovered a remarkable property of the contractile ring, a structure required for cell division. Understanding how the contractile ring works to divide the cell may facilitate development of therapies to prevent uncontrolled cell division in cancer.
Health Insurance

Terrence Higgins Trust Welcomes Professor Peter Piot To Board Of Trustees

Professor Peter Piot, Director of the Institute for Global Health at Imperial College, is joining the Board of Trustees at Terrence Higgins Trust (THT) this month. Professor Piot was the former Executive Director of UNAIDS and Under Secretary-General of the United Nations. He comes from a distinguished academic and scientific background focusing on AIDS and women"s health in the developing world. In the 1980s he launched a series of research projects in Africa. Project SIDA in Zaire, was the first international project on AIDS in Africa and is widely acknowledged as having provided the foundations of our understanding of HIV infection in the continent. Born in Belgium, Professor Piot is fluent in three languages and is the author of 16 books and more than 500 scientific articles. He has received numerous awards for scientific and societal achievement, and was knighted as a Baron by King Albert II of Belgium in 1995. Sir Nick Partridge, Chief Executive at THT said "We"re delighted that Professor Piot is joining our Board of Trustees. He brings with him a wealth of experience and expertise and is very well respected in the HIV sector worldwide. Professor Piot will further strengthen the board to help lead Terrence Higgins Trust in the coming years." Professor Piot said "I am thrilled to be able to support Terrence Higgins Trust in this way. More people are living with HIV in the UK than ever before and rates of many sexually transmitted infections are rising. Community organisations like THT play a vital role offering testing, information and support to those affected." THT"s Board of Trustees are responsible for setting the overall strategy and direction of the charity, and for ensuring THT uses its res effectively in pursuit of its mission statement. There are ten members of the Board, including Professor Piot. Terrence Higgins Trust


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

İ Copyright 2009